Looking back at 2021
With 2021 soon coming to a close, I wanted to take a moment to reflect on the year. It was far from my prepandemic version of “normal,” although, in my opinion, it was an improvement from 2020 in many ways.
I also thought about all of the professionals in industry I got to speak with this year. No matter the role or field, every interviewee said something that surprised or stuck with me. In this column, I wanted to share those thoughts and recap what I’ve learned this year.
Inspiring stories from industry
The COVID-19 pandemic remained at the forefront of my mind, and I was amazed at the coordination and speed with which vaccines were developed and deployed in the United States. It was a privilege to talk to Amit Srivastava in a two-part column about his work at Pfizer, one of the partners, with BioNTech, responsible for the first COVID-19 vaccine.
Srivastava shared his career journey through academia, the nonprofit world and, finally, industry in a column that emphasized how many opportunities are truly out there for those with scientific training. He was also directly involved in the successful development of the COVID-19 vaccine, and hearing about how he worked on the pandemic response was fascinating.
On another note, as a woman in science, I’m constantly inspired by the lives and career paths of other women scientists, and this year was no different. Diana Azurdia spoke about how she used her graduate school experience to build better mentorship and retention initiatives at UCLA, specifically with the goal to support diversity and inclusion. The measurable effects of her work and her clear passion for her job were inspiring and made me realize how powerful it can be to apply your own experience to your work.
Dominique Gales–Badea had a related mission. She is a field application scientist who spoke about how part of her motivation to move to industry was to improve diversity and inclusion. She was clearly committed to sharing her knowledge and experience with others looking to break into the field — she even encouraged readers interested in her career journey to reach out to her, and I think her advice would be helpful for anyone considering a path like hers.
One thing I appreciated was her complete willingness to talk about salary. This is something I routinely ask about during interviews, but a lot of people shy away from. Knowing salary ranges can be extremely useful when considering sustainable career paths and making sure you aren’t getting underpaid for your work. Stay tuned for a future column on negotiating skills, something I never learned in academia.
The many possibilities industry provides
As with previous years, I was surprised and amazed by the variety of jobs available in industry. From medical leads to account managers, the professionals I talked to proved time and time again that industry is more than research and development. But that’s not to say there isn’t amazing science happening in industry, and satisfying work can mean different things to different people.
Sadiye Amcaoglu Rieder's passion remains in the lab. She has used her research training in her role as a senior scientist. Meanwhile, Jake Courtney wanted to focus on sustainable science and found the perfect fit at a biotechnology company doing research on synthetic biology. It was clear how many opportunities are out there in industry, regardless of your niche.
I also enjoyed learning more about the particularities of working in industry since I don’t have that experience myself. The language used is a bit different than in academic or nonprofit careers, and job titles are no exception. Knowing what these titles are and what responsibilities they entail gave insight into climbing the ladder in industry. Understanding this hierarchy can be helpful for those looking to move into industry but aren’t sure which positions they may be qualified for. I also addressed what to expect and how to handle performance reviews.
I wrote about a couple of resources that may be helpful for anyone looking to make a career change. There are plenty of free biotechnology and pharmaceutical-related training courses that you can take advantage of to get started and beef up your experience. Also, if there’s one thing I have learned, it is to not limit yourself. Everyone (and I do mean everyone) has skills that are applicable in industry, and it’s important to leverage your transferable skills when applying for industry-related positions.
In sum, everyone I spoke with proved how multilayered industry is and how many experiences are out there. I may have mentioned before that I’ve been looking for new positions myself, so next year I hope to have content related to conducting informational interviews, how to negotiate a job offer and more.
For now, happy holidays and happy new year!
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition weekly.
Learn moreFeatured jobs
from the
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Careers
Careers highlights or most popular articles
Upcoming opportunities
Friendly reminder: Book a recruiter table at ASBMB's career and education fair by Nov. 30 to secure early-bird pricing! Just added: Applications are being accepted for a post-bac at Dartmouth Cancer Center.
Upcoming opportunities
Just added: Register for ASBMB's virtual session on thriving in challenging academic or work environments.
Who decides when a grad student graduates?
Ph.D. programs often don’t have a set timeline. Students continue with their research until their thesis is done, which is where variability comes into play.
Upcoming opportunities
Submit an abstract for ASBMB's meeting on ferroptosis!
Join the pioneers of ferroptosis at cell death conference
Meet Brent Stockwell, Xuejun Jiang and Jin Ye — the co-chairs of the ASBMB’s 2025 meeting on metabolic cross talk and biochemical homeostasis research.
A brief history of the performance review
Performance reviews are a widely accepted practice across all industries — including pharma and biotech. Where did the practice come from, and why do companies continue to require them?